KANSAI NEROLAC has announced its results for the year ended March 2024. Let us have a look at the detailed performance review of the company during FY23-24.
No. of Mths Year Ending | 12 Mar-23* | 12 Mar-24* | % Change | |
---|---|---|---|---|
Net Sales | Rs m | 75,427 | 78,014 | 3.4% |
Other income | Rs m | 260 | 919 | 253.7% |
Total Revenues | Rs m | 75,687 | 78,933 | 4.3% |
Gross profit | Rs m | 8,180 | 16,890 | 106.5% |
Depreciation | Rs m | 1,801 | 1,905 | 5.8% |
Interest | Rs m | 290 | 292 | 0.7% |
Profit before tax | Rs m | 6,349 | 15,612 | 145.9% |
Tax | Rs m | 1,664 | 3,854 | 131.6% |
Profit after tax | Rs m | 4,685 | 11,759 | 151.0% |
Gross profit margin | % | 10.8 | 21.6 | |
Effective tax rate | % | 26.2 | 24.7 | |
Net profit margin | % | 6.2 | 15.1 |
Don't Miss: Key Information for Long-term Investors
No. of Mths Year Ending | 12 Mar-23* | 12 Mar-24* | % Change | |
---|---|---|---|---|
Networth | Rs m | 45,300 | 55,667 | 22.9 |
Current Liabilities | Rs m | 15,067 | 15,206 | 0.9 |
Long-term Debt | Rs m | 47 | 150 | 219.8 |
Total Liabilities | Rs m | 63,064 | 74,097 | 17.5 |
Current assets | Rs m | 38,031 | 47,490 | 24.9 |
Fixed Assets | Rs m | 25,033 | 26,606 | 6.3 |
Total Assets | Rs m | 63,064 | 74,097 | 17.5 |
Particulars | No. of months | 12 | 12 | % Change |
---|---|---|---|---|
Year Ending | Mar-23 | Mar-24 | ||
Cash Flow from Operating Activities | Rs m | 4,083 | 9,030 | 121.2% |
Cash Flow from Investing Activities | Rs m | -2,269 | -5,898 | - |
Cash Flow from Financing Activities | Rs m | -1,326 | -2,488 | - |
Net Cash Flow | Rs m | 487 | 644 | 32.2% |
No. of Mths Year Ending | 12 Mar-23* | 12 Mar-24* | |
---|---|---|---|
Sales per share (Unadj.) | Rs | 140.0 | 96.5 |
TTM Earnings per share | Rs | 8.7 | 14.5 |
Diluted earnings per share | Rs | 5.8 | 14.5 |
Price to Cash Flow | x | 32.1 | 17.8 |
TTM P/E ratio | x | 44.4 | 19.4 |
Price / Book Value ratio | x | 5.3 | 4.4 |
Market Cap | Rs m | 240,884 | 243,551 |
Dividends per share (Unadj.) | Rs | 2.7 | 3.8 |
Current Ratio: The company's current ratio improved and stood at 3.1x during FY24, from 2.5x during FY23. The current ratio measures the company's ability to pay short-term and long-term obligations.
Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 54.4x during FY24, from 22.9x during FY23. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.
Return on Equity (ROE): The ROE for the company improved and stood at 21.1% during FY24, from 10.3% during FY24. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.
Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 28.5% during FY24, from 14.6% during FY23. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.
Return on Assets (ROA): The ROA of the company improved and stood at 16.3% during FY24, from 7.9% during FY23. The ROA measures how efficiently the company uses its assets to generate earnings.
No. of Mths Year Ending | 12 Mar-23* | 12 Mar-24* | |
---|---|---|---|
Current ratio | x | 2.5 | 3.1 |
Debtors’ Days | Days | 6 | 6 |
Interest coverage | x | 22.9 | 54.4 |
Debt to equity ratio | x | 0.0 | 0.0 |
Return on assets | % | 7.9 | 16.3 |
Return on equity | % | 10.3 | 21.1 |
Return on capital employed | % | 14.6 | 28.5 |
To see how KANSAI NEROLAC has performed over the last 5 years, please visit here.
Over the last one year, KANSAI NEROLAC share price has moved down from Rs 289.1 to Rs 282.6, registering a loss of Rs 6.5 or around 2.3%.
Overall, the S&P BSE SENSEX is up 22.2% over the year.
(To know more, check out historical annual results for KANSAI NEROLAC and quarterly results for KANSAI NEROLAC)
KANSAI NEROLAC currently trades at Rs 265.2 per share. You can check out the latest share price performance of KANSAI NEROLAC here...
The revenues of KANSAI NEROLAC stood at Rs 78,933 m in FY24, which was up 4.3% compared to Rs 75,687 m reported in FY23.
KANSAI NEROLAC's revenue has grown from Rs 53,055 m in FY20 to Rs 78,933 m in FY24.
Over the past 5 years, the revenue of KANSAI NEROLAC has grown at a CAGR of 10.4%.
The net profit of KANSAI NEROLAC stood at Rs 11,759 m in FY24, which was up 151.0% compared to Rs 4,685 m reported in FY23.
This compares to a net profit of Rs 3,432 m in FY22 and a net profit of Rs 5,257 m in FY21.
Over the past 5 years, KANSAI NEROLAC net profit has grown at a CAGR of 22.9%.
The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.
This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.
The cash flow statement of KANSAI NEROLAC reveals:
Here's the cash flow statement of KANSAI NEROLAC for the past 5 years.
(Rs m) | FY20 | FY21 | FY22 | FY23 | FY24 |
---|---|---|---|---|---|
From Operations | 5,951 | 6,459 | 248 | 4,083 | 9,030 |
From Investments | -3,762 | -4,528 | 2,495 | -2,269 | -5,898 |
From Financial Activity | -1,407 | -2,742 | -3,093 | -1,326 | -2,488 |
Net Cashflow | 782 | -802 | -361 | 487 | 644 |
Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.
The ratio/financial analysis of KANSAI NEROLAC reveals:
Here's the ratio/financial analysis of KANSAI NEROLAC for the past 5 years.
FY20 | FY21 | FY22 | FY23 | FY24 | |
---|---|---|---|---|---|
Operating Profit Margin (%) | 15.2 | 17.0 | 10.2 | 10.8 | 21.6 |
Net Profit Margin (%) | 9.8 | 10.4 | 5.4 | 6.2 | 15.1 |
Debt to Equity Ratio (x) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Equitymaster requests your view! Post a comment on "KANSAI NEROLAC 2023-24 Annual Report Analysis". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!